Results 91 to 100 of about 713,344 (287)
Noninferiority testing in cost-minimization studies: Practical issues concerning power analysis [PDF]
, 2006 Objectives: In cost-minimization studies, it is important to establish noninferiority in the clinical effect of the treatments under investigation. The relationship between the proportion of patients reaching the end point in a study, equivalence limit ...
Stolk, RP +9 more
core +1 more source
Cost-effectiveness analysis results.
, 2022 Cost-effectiveness analysis results.
Mihaela Nica (3357893) +5 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Фармакоэкономика, 2015 : pharmacoeconomic study of treatment primary open-angle glaucoma with fix combination of carbonic anhydrise inhibitors and betablockers by mean of cost-utility, willingness-to-pay, cost minimization and budget impact analysis was conducted. Results have
M. V. Protsenko
doaj
, 2020 This is the second paper in a series looking at pharmacoeconomic methods. The first paper discussed how costs are identified for pharmacoeconomic studies.
BPharm D Newby +3 more
core
Cost-benefit analysis of Australian Federal Police counter-terrorism operations at Australian airports [PDF]
, 2013 The terrorist attacks of 11 September 2001 highlighted the vulnerabilities of airports and aircraft. Further attacks in 2002, 2007 and 2009, have led to major government reforms in passenger processing and airport access.
John Mueller, Mark G. Stewart
core
Screening Routine Clinical Notes for Epilepsy Surgery Candidates Using Large Language Models
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Epilepsy surgery is severely underutilized despite proven efficacy, with substantial under‐referral of eligible patients in routine clinical practice. This study evaluated the potential role of large language models (LLMs) as decision‐support tools for screening unstructured clinical notes to identify epilepsy surgery candidates and ...
Uriel Fennig +9 more
wiley +1 more source
Cost-Minimization Analysis of Risk-Stratified Hematuria Evaluation
, 2016 Background/Aims: Up to 30% of adults have hematuria; however, 5% or fewer have a significant finding such as bladder or kidney cancer. Current guidelines recommend cystoscopy and imaging for all who meet criteria; however, the guidelines acknowledge ...
Kirchner, H. Lester +7 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source
Berkala KedokteranDiabetes According to WHO (2016) is a serious chronic disease that occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces.
Farah Noor Ain +2 more
doaj +1 more source